Skip to Main Content

Paper Details

Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.
Int J Cancer
46
2017
Author NameAffiliation
Silvano BosariFondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico
Silvano BosariUniversity of Milan
  • 1 - 2

Datasets

Release 1.2